Alerts will be sent to your verified email
Verify Email
LINKPH
|
Link Pharma Chem
|
Rekvina Labs
|
Colinz Laboratories
|
|
|---|---|---|---|
|
Operational Metrics
|
|||
|
Financials
|
|||
|
5 yr Average ROE
|
1.59 % | -118.34 % | 4.71 % |
|
5yr average Equity Multiplier
|
1.99 | 6.31 | 1.29 |
|
5yr Average Asset Turnover Ratio
|
1.33 | 0.0 | 0.64 |
|
5yr Avg Net Profit Margin
|
-0.06 % | 0.0 | 5.84 % |
|
Price to Book
|
0.99 | 0.0 | 1.32 |
|
P/E
|
0.0 | 0.0 | 26.49 |
|
5yr Avg Cash Conversion Cycle
|
82.44 Days | 0.0 | -11.59 Days |
|
Inventory Days
|
64.96 Days | 0.0 | 56.66 Days |
|
Days Receivable
|
72.97 Days | 0.0 | 42.5 Days |
|
Days Payable
|
84.21 Days | 0.0 | 89.1 Days |
|
5yr Average Interest Coverage Ratio
|
2.35 | -132.32 | 11.55 |
|
5yr Avg ROCE
|
5.35 % | -100.9 % | 6.71 % |
|
5yr Avg Operating Profit Margin
|
3.76 % | 0.0 | 7.54 % |
|
5 yr average Debt to Equity
|
0.49 | -0.19 | 0.07 |
|
5yr CAGR Net Profit
|
n/a | 18.47 % | 18.95 % |
|
5yr Average Return on Assets
|
0.6 % | -132.46 % | 3.68 % |
|
Shareholdings
|
|||
|
Promoter Holding
|
51.49 % | 41.3 % | 66.0 % |
|
Share Pledged by Promoters
|
0.0 | 0.0 | 0.0 |
|
Change in Promoter Holding (3 Yrs)
|
0.0 | 0.0 | 0.0 |
|
Change in Mutual Fund Holding (3 Yrs)
|
0.0 | 0.0 | 0.0 |
|
Link Pharma Chem
|
Rekvina Labs
|
Colinz Laboratories
|
|
|---|---|---|---|
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|